TheEdgeResearch
Home / Stocks / CSBR

Champions Oncology, Inc. (CSBR)

NASDAQ Healthcare Biotechnology
$4.34 ▼ -1.36%
Market Cap
$60.4M
Sector
Healthcare
Industry
Biotechnology
Beta
0.45
52-Wk Range
4.315-8.31
CEO
Robert Brainin
Country
US
Currency
USD

Champions Oncology, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Hackensack, NJ, US. The stock last traded at $4.34, down 1.36% on the session, giving a market capitalisation of $60.4M. On trailing twelve-month figures it carries a trailing P/E of -54.94, a net margin of -1.9%. Its beta of 0.45 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-54.94
Price / Sales
1.00
Price / Book
15.49
EV / EBITDA
149.93
Gross margin
49.3%
Operating margin
-1.7%
Net margin
-1.9%
Return on equity
—
Debt / equity
2.82
Current ratio
1.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
214
IPO date
2007-02-02
Headquarters
Hackensack, NJ, US
About Champions Oncology, Inc.

Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.

Comparable companies

Champions Oncology, Inc. is most often compared with the following Healthcare names:

ARTVATRACNTBIFRXIMAKLRSMGXORMPSTROSTTK
More research on CSBR
CSBR technical analysis CSBR TheEdge Score Compare against peers
Open full interactive analysis & DCF →